Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

Summary

The goal of this observational study is to learn about the added diagnostic and prognostic value of advanced medical imaging procedures in cervical cancer, endometrial cancer and ovarian cancer. The main questions it aims to answer are: * Does advanced medical imaging predict survival? * Can advanced medical imaging improve radiotherapy target planning? * Are advanced medical imaging results associated with risk markers found in tumor tissue? Participants will * Undergo four additional imaging procedures, as compared to clinical routine examinations, two at baseline and two after three months. * Be subject to clinical follow-up for five years.

Eligibility

Inclusion Criteria:

* Previously untreated primary cervical, endometrial, or strongly suspected epithelial ovarian cancer.
* Known clinical FIGO stage.
* \>18 years old.
* No other known current or previous malignancy within the last 10 years.

Exclusion Criteria:

* Imaging findings suggestive of other primary malignancy.
* Previously included suspected epithelial ovarian cancer, later confirmed to be other diagnosis than epithelial ovarian cancer or "cancer abdominis".
* MRI incompatible devices or patient unable to undergo MRI.

Conditions4

Browse More Trials